# Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study

> **NCT03572166** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 177 (actual)

## Conditions studied

- Diabetes Insipidus
- Polydipsia, Primary

## Interventions

- **DIAGNOSTIC_TEST:** Arginine infusion
- **DIAGNOSTIC_TEST:** Hypertonic saline infusion

## Key facts

- **NCT ID:** NCT03572166
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-03
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03572166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03572166, "Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03572166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*